期刊文献+

2型固有淋巴细胞在肝脏疾病免疫调控中的作用 被引量:1

Role of type 2 innate lymphoid cells in immunoregulation of liver diseases
下载PDF
导出
摘要 固有淋巴细胞(ILCs)是新发现的一类固有免疫细胞,2型固有淋巴细胞(ILC2s)是其中一个细胞亚群,在受到IL-25、IL-33等刺激后可产生2型辅助型T淋巴细胞(Th2)因子,具有启动和维持2型免疫反应的作用。ILC2s属于固有免疫细胞,又具有调节适应性免疫的功能,参与炎症、组织修复、细胞增殖、代谢、调节免疫等病理生理过程。肝脏是人体重要的代谢器官和免疫器官,含有多种免疫细胞。ILC2s在肝脏疾病中具有调节免疫、调控炎症以及组织修复等重要作用。总结了ILC2s的生理功能及其在肝脏疾病发病机制中的免疫调控机制。 Innate lymphoid cells( ILCs) are a new type of innate immune cells discovered in recent years,and type 2 ILCs( ILC2 s) are a subset of ILCs and can produce type 2 T-helper cytokines after being activated by interleukin-25 and interleukin-33,which helps to start and maintain type 2 immune response.ILC2 s belong to innate immune cells and can regulate adaptive immunity and participate in various pathophysiological processes such as inflammation,tissue repair,cell proliferation,metabolism,and immunoregulation.The liver is recognized as an important metabolic and immune organ in the human body and contains several types of immune cells.ILC2 s can regulate immune response,inflammation,and tissue repair in liver diseases.This article summarizes the physiological function of ILC2 s and the immunomodulatory mechanism of ILC2 s in liver disease.
作者 韩静 郭金波 张晓岚 HAN Jing;GUO Jinbo;ZHANG Xiaolan(Department of Gastroenterology, East Branch of The Second Hospital of Hebei Medical University, Shijiazhuang 050035, China)
出处 《临床肝胆病杂志》 CAS 北大核心 2019年第9期2124-2128,共5页 Journal of Clinical Hepatology
基金 河北省自然科学基金(H2018206363)
关键词 固有淋巴细胞 肝疾病 免疫 先天 innate lymphoid cells liver diseases immunity,innate
  • 相关文献

参考文献5

二级参考文献37

  • 1Bertoletti A, Naoumov NV. Translation of immunological knowledge into better treatments of chronic hepatitis B[J]. J Hepatol, 2003, 39(1): 115-124.
  • 2Yang PL, Ahhage A, Chung J, et al. Immune effeetors required for hepatitis B virus clearance [J]. Proc Natl Aead Sci USA, 2010, 107(2): 798-802.
  • 3Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection [J]. Gut, 2012, 61(12): 1754-1764.
  • 4Diefenbach A, Colonna M, Koyasu S. Development, differentiation, and diversity of innate lymphoid ceils [J]. Immunity, 2014, 41(3): 354-365.
  • 5Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function[J]. Ann Rev Immunol; 2012, 30: 647-675.
  • 6Dunn C, Brunetto M, Reynolds G, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage[J]. J Exp Med, 2007, 204(3): 667-680.
  • 7Zhang Z, Zhang S, Zou Z, et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients[J]. Hepatology, 2011, 53(1): 73-85.
  • 8Sakai N, Van Sweringen HL, Quillin RC, et al. Interleukin- 33 is hepatoprotective during liver isehemia/reperfusion in mice[J]. Hepatology, 2012, 56(4): 1468-1478.
  • 9Spits H, Artis D, Colonna M, et al. Innate lymphoid cells-- a proposal for uniform nomenclature [j]. Nat Rev Immunol, 2013, 13(2): 145-149.
  • 10Sonnenberg GF, Monticelli LA, Alenghat T, et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria[J]. Science, 2012, 336(6086): 1321-1325.

共引文献47

同被引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部